quinazolines has been researched along with Diathesis in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 3 (42.86) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, EJ; Hwang, S; Im, SS; Kim, J; Kim, JH; Lee, JH; Rho, JK; Shin, DM; Son, J | 1 |
| Anaclerico, B; Andriani, A; Baldacci, E; Breccia, M; Cedrone, M; Cimino, G; Di Veroli, A; Latagliata, R; Mazzucconi, MG; Montanaro, M; Montefusco, E; Paoloni, F; Porrini, R; Rago, A; Santoro, C; Scaramucci, L; Spadea, A; Spirito, F; Villivà, N | 1 |
| Cheson, BD; Narkhede, M | 1 |
| Bergmann, F; Griesshammer, M; Koschmieder, S; Kreher, S; Matzdorff, A; Ochsenreither, S; Pabinger, I; Petrides, PE; Riess, H; Tiede, A; Trappe, RU | 1 |
| Bartralot, R; Bodet, D; García-Patos, V; Heras, C; Mollet, J | 1 |
| Hirakawa, K; Inoue, H; Mimori, K; Mori, M; Nagahara, H; Ohira, M; Sawada, T; Zhang, X | 1 |
| Czuczwar, SJ; Janusz, W; Kleinrok, Z; Szczepanik, B | 1 |
1 review(s) available for quinazolines and Diathesis
| Article | Year |
|---|---|
Copanlisib in the treatment of non-Hodgkin lymphoma.
Topics: Biomarkers; Clinical Trials as Topic; Disease Management; Disease Susceptibility; Humans; Hyperglycemia; Hypertension; Lymphoma, Non-Hodgkin; Molecular Targeted Therapy; Phosphatidylinositol 3-Kinase; Phosphoinositide-3 Kinase Inhibitors; Prognosis; Pyrimidines; Quinazolines; Signal Transduction; Treatment Outcome | 2020 |
6 other study(ies) available for quinazolines and Diathesis
| Article | Year |
|---|---|
BIX01294 inhibits EGFR signaling in EGFR-mutant lung adenocarcinoma cells through a BCKDHA-mediated reduction in the EGFR level.
Topics: 3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide); Adenocarcinoma of Lung; Apoptosis; Azepines; Biomarkers; Cell Line, Tumor; Citric Acid Cycle; Disease Susceptibility; Drug Resistance, Neoplasm; Energy Metabolism; ErbB Receptors; Histone Demethylases; Humans; Immunohistochemistry; Mitochondria; Models, Biological; Protein Kinase Inhibitors; Quinazolines; Signal Transduction | 2021 |
Anagrelide in Essential Thrombocythemia (ET): Results from 150 patients over 25 years by the "Ph1-negative Myeloproliferative Neoplasms Latium Group".
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Anemia; Disease Management; Disease Susceptibility; Drug Substitution; Female; Follow-Up Studies; Health Care Surveys; Humans; Italy; Male; Middle Aged; Pregnancy; Pregnancy Complications, Hematologic; Prognosis; Quinazolines; Retreatment; Retrospective Studies; Thrombocythemia, Essential; Thrombosis; Treatment Outcome; Young Adult | 2020 |
Prophylaxis and management of venous thromboembolism in patients with myeloproliferative neoplasms: consensus statement of the Haemostasis Working Party of the German Society of Hematology and Oncology (DGHO), the Austrian Society of Hematology and Oncolo
Topics: Anticoagulants; Disease Susceptibility; Drug Interactions; Female; Hemorrhage; Heparin, Low-Molecular-Weight; Humans; Hydroxyurea; Incidence; Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative; Male; Myeloproliferative Disorders; Phlebotomy; Platelet Aggregation Inhibitors; Postoperative Complications; Pregnancy; Pregnancy Complications, Hematologic; Preoperative Care; Protein Kinase Inhibitors; Quinazolines; Secondary Prevention; Thrombophilia; Venous Thromboembolism; von Willebrand Diseases | 2014 |
[Contribution to acneiform eruptions by epidermal growth factor receptor inhibitors].
Topics: Acneiform Eruptions; Adenocarcinoma; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cetuximab; Colonic Neoplasms; Disease Susceptibility; Drug Eruptions; ErbB Receptors; Gefitinib; Humans; Liver Neoplasms; Lung Neoplasms; Male; Neoplasm Proteins; Quinazolines; Staphylococcal Skin Infections; Superinfection | 2006 |
Mutations of epidermal growth factor receptor in colon cancer indicate susceptibility or resistance to gefitinib.
Topics: Antineoplastic Agents; Blotting, Western; Colonic Neoplasms; Disease Susceptibility; Drug Resistance, Neoplasm; ErbB Receptors; Gefitinib; Humans; Mutagenesis, Site-Directed; Mutation; Quinazolines; Tumor Cells, Cultured | 2008 |
Influence of CGS 15943 A (a nonxanthine adenosine antagonist) on the protection offered by a variety of antiepileptic drugs against maximal electroshock-induced seizures in mice.
Topics: Adenosine; Animals; Anticonvulsants; Disease Susceptibility; Drug Interactions; Electroshock; Epilepsy; Male; Mice; Motor Activity; Quinazolines; Triazoles | 1991 |